Skip to main content

Page last checked

United Kingdom · Mounjaro

Mounjaro on the NHS, and what the UK price means

In England, NHS services can use Mounjaro for weight management, and access comes in stages. Specialist services start at BMI 35 plus one weight-related condition. For primary care in 2026/27, Cohorts I and II need BMI 35 plus four listed conditions. NICE lists £133–£330 for four weeks and excludes VAT. That is not what the NHS pays or one set price for private patients.

Source: NICE and NHS England, checked 2026-08-16

What matters first

Specialist entry
BMI 35 plus one listed condition
Primary care · 2026/27
BMI 35 plus four listed conditions
Four-week list price
£133–£330 before VAT
Patient cost
£9.90 per item unless exempt

Meeting the rules does not guarantee a prescription. A clinician decides whether the drug is right for the patient. The local service must also have a way to assess and support the patient. These obesity rules are separate from those for type 2 diabetes.

The published number

Mounjaro list price by dose

Four-week supply

NICE publishes four price points for six KwikPen strengths. These are list prices. They are not private offers or the price paid by the NHS.

NICE Mounjaro list prices for a four-week supply of pre-filled pens, excluding VAT.
Pen strengthFour-week list priceWhat the figure is
2.5 mg£133.00NICE list price · excluding VAT
5 mg£180.00NICE list price · excluding VAT
7.5 mg and 10 mg£255.00NICE list price · excluding VAT
12.5 mg and 15 mg£330.00NICE list price · excluding VAT

List price

NICE states these are list prices for a four-week supply of pre-filled pens, excluding VAT.

NHS price

The NHS purchase price is commercial in confidence, so the amount the NHS pays is not published in the guidance.

Private price

A private prescription requires a clinical consultation, and the final private patient price varies by prescriber and dispensing pharmacy. No national private retail price exists.

What an NHS prescription costs in England

£9.90 per item unless exempt. That is the NHS prescription charge per item, not Mounjaro’s drug price. NHS exemptions still apply.

NHS England · 2026/27

Two access settings, two thresholds

Specialist services and primary care do not use the same gate. NHS England expands primary care by cohort. During 2026/27, that includes the original Cohort I and the new Cohort II.

NHS England Mounjaro weight-management access by care setting, checked 16 August 2026.
SettingCurrent positionBMIConditionsWhat still applies
Specialist weight management serviceAvailable under the full NICE cohortAt least 35At least 1 weight-related comorbidityA prescribing clinician must consider treatment appropriate. Local integrated care boards may still prioritize referrals.
Primary care — 2026/27 rolloutCohorts I and IIAt least 35At least 4 qualifying comorbiditiesThe current funded rollout combines the original BMI 40+ cohort with the new BMI 35–39.9 cohort.

The five qualifying conditions

  • 1Hypertension
  • 2Dyslipidaemia
  • 3Obstructive sleep apnea
  • 4Cardiovascular disease
  • 5Type 2 diabetes mellitus

NHS England says the BMI threshold is usually reduced by 2.5 kg/m² for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds.

This rollout table is for NHS England. Scotland, Wales and Northern Ireland run separate health services with their own rules.

Questions people actually ask

Who will get Mounjaro on the NHS?

In an NHS England specialist service, the NICE cohort starts at BMI 35 plus one weight-related condition. The 2026/27 primary-care rollout is narrower. It starts at BMI 35 plus four listed conditions, with the adjustment shown above.

Can I ask my GP for Mounjaro?

You can ask how your local NHS pathway works. NHS England funds primary-care access in phases. Local integrated care boards set up the assessment route. Meeting the cohort does not require a clinician to prescribe it.

What does Mounjaro cost in the UK?

NICE lists £133 to £330 for four weeks, based on strength and excluding VAT. The NHS price is confidential. In England, a patient who is not exempt pays £9.90 per item. Private prices vary, so one seller’s offer is not treated as a national price.

What remains uncertain

  • It does not apply NHS England’s rollout rules to Scotland, Wales or Northern Ireland.
  • It does not treat NICE’s list price, the confidential NHS price and a private patient’s bill as the same number.
  • It does not say that meeting a BMI and comorbidity threshold guarantees assessment or a prescription.
  • It does not use the obesity pathway to answer the separate type 2 diabetes criteria.

Medically reviewed by Jennifer Montecillo, MD · non-practicing medical reviewer

Reviewed 2026-08-16

Continue through the page

Where the money question gets answered

3 molecules, each with its own page of what exists and what it costs.

Where UK Wegovy access differs from Mounjaro

England’s service rules are not copied onto Scotland, Wales or Northern Ireland.

What “research use only” changes in Australia

An ARTG-listed peptide medicine does not make every peptide product approved.

Who can request Health Canada Special Access

A 90-day quantity limit is a boundary inside eligible cases, not a general import permission.

The sourcing rules behind every figure here

Why a label band and a trial percentage are never averaged together.

Sources

  1. TA1026, section 2 — indication and list price for tirzepatide · National Institute for Health and Care Excellence · retrieved 2026-08-16
  2. Weight management injections — Mounjaro access in England · NHS England · retrieved 2026-08-16
  3. Interim commissioning guidance for NICE TA1026 · NHS England · retrieved 2026-08-16
  4. Tirzepatide — NHS medicine guide · NHS · retrieved 2026-08-16
  5. GLP-1 medicines for weight loss and diabetes: what you need to know · Medicines and Healthcare products Regulatory Agency · retrieved 2026-08-16
  6. Help with NHS prescription costs · NHS Business Services Authority · retrieved 2026-08-16